L'intérêt à découvert pour Presidio Property Trust donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Presidio Property Trust. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Presidio Property Trust (NASDAQ:SQFTP) Stock, Rapport sur les intérêts à découvert

Presidio Property Trust

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Presidio Property Trust, Inc. - 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share

Presidio Property Trust Inc

Macquarie analyst Steve Koenig upgrades Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) from Neutral to Outperform and lowers the price target from $317 to $270.

News

Upgrades

Price Target

Analyst Ratings

TEAM

Macquarie Upgrades Atlassian to Outperform, Lowers Price Target to $270

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) with a Buy and maintains $18 price target.

GOVX

D. Boral Capital Maintains Buy on Geovax Labs, Maintains $18 Price Target

Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) has just triggered <a href="https://www.benzinga.com/topic/death-cross">a technical Death Cross</a> — and it's not the only signal weighing on investor sentiment.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0410"><img loading="lazy" decoding="async" width="628" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10130413/Screenshot-2025-04-10-at-10.34.03-PM.png" alt="" class="wp-image-866448" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10130413/Screenshot-2025-04-10-at-10.34.03-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10130413/Screenshot-2025-04-10-at-10.34.03-PM-300x236.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0410" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
<h2 class="wp-block-heading">Technical Warning signs Pile Up For TSM Stock</h2>
Technically, things look bleak. With shares down 25% year to date and 11% in the past month, TSM stock has sunk below its eight, 20, and 50-day simple moving averages—a textbook sign of a strongly bearish trend. Even the 200-day simple moving average, at $184.40, sits far above TSM stock, at $150.69, offering little comfort.
The Moving Average Convergence Divergence (MACD) stands at a negative 9.07, flashing more red, while the Relative Strength Index (RSI) at 37.85 signals it&#8217;s approaching oversold territory.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44724362/chip-stocks-surge-as-trump-pauses-tariffs-for-us-allies-targets-china-with-125-duties">Chip Stocks Surge As Trump Pauses Tariffs For US Allies, Targets China With 125% Duties</a>
<h2 class="wp-block-heading">Trump Turns Up The Heat On Chipmakers</h2>
But here&#8217;s the kicker: just as TSM tries to steady the ship, President Donald Trump adds political torque. The president claimed he threatened the chip giant with a 100% tax if it didn't make chips in the U.S., <a href="https://www.businessinsider.com/trump-threatened-tsmc-100-percent-tax-make-chips-in-us-2025-4">reported</a> Business Insider. "These chip companies are loaded," he said, slamming the CHIPS Act and boasting he didn't need to write checks to make things happen &#8211; just dangle tariffs.
<h2 class="wp-block-heading">A $100 billion Answer- But Is It Enough?</h2>
TSMC, to its credit, has committed over $100 billion to build five U.S. factories, on top of the $65 billion already pledged. Still, the market isn't exactly applauding. Investors are stuck between a death cross and a Trump tax threat &#8211; and both sides sting.
Investors seeking safer exposure to the chip sector may consider diversified ETFs such as the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>), or VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>), which reduce reliance on any single, politically sensitive stock.
With mounting technical pressure and renewed political scrutiny, TSMC shares face a challenging path ahead. Investors may prefer to wait for signs of technical stability and greater policy clarity before reengaging.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/04/44725578/technology-stocks-outperform-after-trumps-tariff-pause-microchip-technology-amd-lead-sector-higher">Technology Stocks Outperform After Trump&#8217;s Tariff Pause: Microchip Technology, AMD Lead Sector Higher</a></li>
</ul>
Photo: Shutterstock

Technicals

Tech

Trading Ideas

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSMC Triggers Death Cross As Trump Tariff Threats Add To Investor Concerns

WIIM

BRBR

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

COKE

FIZZ

PSMT

SISI

SMPL

Shares of several consumer staples stocks are trading higher. The sector may be moving up as investors gravitate towards more defensive assets following market-wide volatility and uncertainty.

<a href="https://cwa-union.org/news/tentative-agreement-att-southwest" title="https://cwa-union.org/news/tentative-agreement-att-southwest">https://cwa-union.org/news/tentative-agreement-att-southwest</a>

CWA Says 4-Year Agreement At AT&T Southwest Includes 14.5% Pay Hike Over Life Of Contract, Additional Healthcare Options

Cryptocurrency analyst Benjamin Cowen is urging caution as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) continues to trade around key levels, warning that the market's recent bounce may not <a href="https://www.benzinga.com/partner/cryptocurrency/25/04/44665090/a-strategy-that-limits-btcs-inherent-volatility-risk-a-deep-dive-into-calamos-etfs">mark the end of volatility.</a>
What Happened: Speaking in his <a href="https://www.youtube.com/watch?v=sKK9yzBhTmI">podcast</a> on Wednesday, Cowen said President Trump&#8217;s 90-day pause on tariff hikes is widely seen as a bullish macro signal, but it may only be a temporary relief. 
"The tariffs on China actually increased, and considering how much business we do with them, that's not something to brush off," he explained.
He emphasized that markets often experience sharp rebounds after a 20% drop, as seen with the S&amp;P 500 recently, but historical analogs suggest those rallies don't always last. "This kind of volatility doesn't just vanish," Cowen noted.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44735975/bitcoin-back-above-80000-what-does-technical-analysis-say">Bitcoin Back Above $80,000: What Does Technical Analysis Say?</a>
Why It Matters: For Bitcoin, Cowen sees $69,000 as critical support and still preserve the overall bullish structure he said but cautioned that losing that level could flip his outlook more bearish.
He added that despite short-term choppiness, Bitcoin continues to hold above its previous 2024 highs — a sign of strength. Still, the macro backdrop remains uncertain and could weigh on risk assets, especially if China-related tensions escalate.
What's Next: Cowen outlined two potential scenarios:
<ul>
<li>If the market mimics prior non-recessionary corrections, Bitcoin could continue climbing.</li>
<li>If it follows the 1998-style playbook, BTC might form an intermediate top in mid-to-late April, then retest recent lows before pushing back to previous highs by July.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44733485/bitcoin-breaks-80000-but-artificial-rally-could-end-in-a-bear-market-in-september-analyst-warns">Bitcoin Breaks $80,000, But &#8216;Artificial Rally&#8217; Could End In A Bear Market In September, Analyst Warns</a></li>
</ul>
Image: Shutterstock

$BTC

Bitcoin Back Below $80,000 After Relief Rally: What's Next?

Communication Workers Of American Says Last Night CWA AT&T Southwest Bargaining Team Announced They Reached Tentative Agreement With AT&T

As gold prices spike to 18-month highs, investors are turning to <a href="https://www.benzinga.com/etfs">ETFs to achieve exposure to the metal </a>without the hassle of direct ownership.
Geopolitical tensions have heightened amid the tariff game and markets continue to swing wildly. Against this backdrop, gold has resumed its role as a safe haven — and a few ETFs stand out for performance and value.
Also Read: <a href="https://www.benzinga.com/news/global/25/04/44742696/hang-seng-skids-into-bear-zone-as-us-china-tariff-war-rattles-global-etfs">Hang Seng Skids Into Bear Zone As US-China Tariff War Rattles Global ETFs</a>
Global physically backed gold ETFs experienced robust inflows of $8.6 billion in March alone, as per recent <a href="https://www.gold.org/goldhub/data/global-gold-backed-etf-holdings-and-flows">figures </a>from the World Gold Council, taking total first quarter inflows to $21 billion — the second-highest quarterly total in dollar terms ever. The only other time inflows were greater? The second quarter of 2020, during the peak of the COVID-19 pandemic-related pandemonium.
North America dominated the surge, with $6.5 billion of March flows and $12.9 billion for the quarter, or approximately 76% of total. This dramatic rise mirrors a larger investor shift to gold, particularly as volatility shakes both equity and bond markets.
Here are three gold ETFs investors might want to have on their watchlist:
Franklin Responsibly Sourced Gold ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FGDL#NYSE">FGDL</a>)
Year-to-date (YTD) Return: 20.83%
Expense Ratio: 0.15%
FGDL is the top performer when it comes to returns this year so far. What makes it stand out is its emphasis on responsibly sourced gold, appealing to investors who care about ESG factors as much as returns.
SPDR Gold MiniShares Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLDM#NYSE">GLDM</a>)
YTD Return: 20.89%
Expense Ratio: 0.10%
A smaller and cheaper sibling to the heavy-hitting SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), GLDM provides low-cost investors with direct ownership of physical gold without giving up liquidity.
iShares Gold Trust Micro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAUM#NYSE">IAUM</a>)
YTD Return: 20.91%
Expense Ratio: 0.09%
Tailored for retail investors, this ETF provides good performance at ultra-low costs (the lowest in the space today) — an effective play on the gold theme.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/04/44730455/bearish-sentiment-hits-7-week-high-mimicking-35-year-old-record-which-marked-the-bottom-of-the-october-1990-bear-market">Bearish Sentiment Hits 7-Week High, Mimicking 35-Year Old Record Which Marked The Bottom Of The October 1990 Bear Market</a>
<h1 class="wp-block-heading">Why the Gold Rush Now?</h1>
This increased demand for gold is occurring in the face of increasing uncertainty in global markets, fueled primarily by the latest news in U.S. trade policy.
Earlier this week, President Donald Trump <a href="https://www.benzinga.com/topic/tariffs">imposed tariffs on 60 nations</a>, causing a global risk-off sentiment. Although he subsequently introduced a <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty">90-day delay of duties</a> for the majority of nations — led by the European Union — the action was not extended to China, which was slapped with a 125% tariff increase. Beijing promptly fired back with an 84% tariff, fueling concerns of an ongoing U.S.-China trade war.
The see-saw tariff policy has had investors grasping for answers. Gold <a href="https://www.bnnbloomberg.ca/markets/gold/2025/04/10/gold-climbs-after-levy-chaos-drives-biggest-gain-in-18-months/#:~:text=Gold%20rose%20again%20after%20posting,last%20week's%20all%2Dtime%20high.">jumped </a>3.3% on Wednesday, then another 1.6% on Thursday, to within $50 of its record high. The metal is up almost 19% year-to-date.
Markets rallied temporarily on the news of the tariff reprieve. The S&amp;P 500 rose almost 10% — its best day since the financial crisis — after hanging by a thread from a bear market. But the rally has not watered down gold&#8217;s appeal, particularly as investors prepare for more uncertainty and possible central bank intervention.
A weakening dollar and anticipation of additional Federal Reserve easing are fueling the rally. Spot gold increased 1.1% to $3,117.15 an ounce in London on Thursday, as the Bloomberg Dollar Spot Index fell for a second day.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44698920/as-trump-tariffs-spark-panic-investors-rush-into-these-5-recession-proof-etfs">As Trump Tariffs Spark Panic, Investors Rush Into These 5 &#8216;Recession-Proof&#8217; ETFs</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Commodities

ETFs

FGDL

GLDM

IAUM

Gold Fever Grips Wall Street: These ETFs Are Striking It Rich

Wells Fargo analyst Elyse Greenspan maintains RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) with a Overweight and lowers the price target from $277 to $271.

Wells Fargo Maintains Overweight on RenaissanceRe Holdings, Lowers Price Target to $271

Wells Fargo analyst Elyse Greenspan maintains Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) with a Equal-Weight and lowers the price target from $370 to $362.

Wells Fargo Maintains Equal-Weight on Everest Group, Lowers Price Target to $362

Wall Street trimmed steep losses in afternoon trading Thursday, following remarks from President Donald Trump, who expressed some optimism about reaching trade <a href="https://www.benzinga.com/topic/china">agreements, particularly with China</a>. 
"Would love to be able to work a deal with China," Trump told reporters at the White House. "I think we will end up working out something good for both nations.&#8221;
Trump raised the tariff on imports from China, America's largest trading partner, to 125% on Wednesday. 
&#8220;I think it&#8217;s going to work out,&#8221; Trump added.
Markets reacted swiftly. By 2:50 p.m. ET: 
<ul>
<li>The S&amp;P 500 — tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) — was down 3.2%</li>
<li>The Nasdaq 100 trimmed its decline to over 3.8%</li>
<li>The Russell 2000 was off 3.68%. </li>
<li>The Dow Jones Industrial Average also recovered, paring earlier losses from over 4% midday to 2.34%.</li>
</ul>
At midday, the S&amp;P 500 was down 4.8%, the Nasdaq 100 had plunged 5.4%, and the Russell 2000 had dropped 5.3%, wiping out nearly half of Wednesday's historic gains.
<h3 class="wp-block-heading">10% Baseline</h3>
Trump also attacked past trade policies, blaming NAFTA for the loss of nearly 90,000 factories and six million jobs—losses he claimed could have been avoided if tariffs had been in place earlier.
"We're going to bring them all back," Trump said.
Trump highlighted that the European Union initially planned to retaliate against U.S. tariffs but held back after seeing the U.S.&#8217;s aggressive stance against China. &#8220;They were very smart,&#8221; he said.
He also mentioned flexibility in tariff negotiations, suggesting that each country or company might be treated differently depending on the circumstances. 
&#8220;It&#8217;s possible that I would consider flexibility for countries and companies,&#8221; Trump said. &#8220;10% tariff is a baseline. But deals are all different, every country is different.&#8221;
Trump laid out potential uses for the money raised through tariffs, including paying down national debt, reducing the budget and creating border walls.
<h3 class="wp-block-heading">Market Reactions: Gold Eyes Record Close</h3>
At last check Thursday, <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a> data showed:
<ul>
<li>Atlassian Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) was down 3.6% </li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) down 7%</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) down 3.73%</li>
<li>Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) down 6%, and </li>
<li>Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) down 3.77%.</li>
</ul>
Yields on 30-year Treasury notes were still 8 basis points higher on the day to 4.82%, yet slightly trimming earlier spike during the session.
Gold, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), traded 2.5% higher to $3,160 per ounce, on track to close at fresh record highs. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 3.9% to below $79,500, erasing nearly all Wednesday&#8217;s gains occurred following the 90-day tariff pause announcement.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44740040/chinas-growth-outlook-dims-as-trumps-125-tariffs-put-millions-of-jobs-at-risk-goldman-warns">China&#8217;s Growth Outlook Dims As Trump&#8217;s 125% Tariffs Put Millions Of Jobs At Risk, Goldman Warns</a></li>
</ul>
Image: Shutterstock

Asia

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

PLTR

TSLA

China Deal Is 'Going To Work Out,' Trump Says As Stocks Bounce From Session Lows

Wells Fargo analyst Elyse Greenspan maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Overweight and raises the price target from $317 to $320.

Wells Fargo Maintains Overweight on Progressive, Raises Price Target to $320

Wells Fargo analyst Elyse Greenspan maintains Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) with a Equal-Weight and raises the price target from $97 to $105.

ROOT

Wells Fargo Maintains Equal-Weight on Root, Raises Price Target to $105

Ratings for AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $492.64, along with a high estimate of $650.00 and a low estimate of $335.00. This current average has increased by 19.26% from the previous average price target of $413.07. 
<img src="https://www.benzinga.com/files/images/story/2025/1744311660_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of AppLovin among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;James Callahan &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $425.00&#x7C;$575.00 &#x7C; 
&#x7C;Matthew Cost &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $350.00&#x7C;$470.00 &#x7C; 
&#x7C;Alec Brondolo &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $386.00&#x7C;$538.00 &#x7C; 
&#x7C;Rob Sanderson &#x7C;Loop Capital &#x7C;Raises &#x7C;Buy &#x7C; $650.00&#x7C;$450.00 &#x7C; 
&#x7C;Jason Bazinet &#x7C;Citigroup &#x7C;Raises &#x7C;Buy &#x7C; $600.00&#x7C;$460.00 &#x7C; 
&#x7C;Martin Yang &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $560.00&#x7C;$480.00 &#x7C; 
&#x7C;Mike Hickey &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $525.00&#x7C;$375.00 &#x7C; 
&#x7C;Cory Carpenter &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $475.00&#x7C;$325.00 &#x7C; 
&#x7C;James Callahan &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $575.00&#x7C;$400.00 &#x7C; 
&#x7C;John Hodulik &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $630.00&#x7C;$440.00 &#x7C; 
&#x7C;Omar Dessouky &#x7C;B of A Securities &#x7C;Raises &#x7C;Buy &#x7C; $580.00&#x7C;$375.00 &#x7C; 
&#x7C;Eric Sheridan &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Neutral &#x7C; $335.00&#x7C;$220.00 &#x7C; 
&#x7C;John Hodulik &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $440.00&#x7C;$315.00 &#x7C; 
&#x7C;Alec Brondolo &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $366.00&#x7C;$360.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AppLovin. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of AppLovin compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of AppLovin's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of AppLovin's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/APP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AppLovin analyst ratings.</a>
<h2>Delving into AppLovin's Background</h2>
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max, and gaming studios, which develop mobile games. AppLovin announced in February 2025 its plans to divest from the lower-margin gaming studios to focus exclusively on the ad tech platform. AppLovin's primary tool for future growth is Axon 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
<h3>Key Indicators: AppLovin's Financial Health</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3M period, AppLovin showcased positive performance, achieving a revenue growth rate of 44.01% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 43.61%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): AppLovin's ROE stands out, surpassing industry averages. With an impressive ROE of 59.04%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AppLovin's ROA stands out, surpassing industry averages. With an impressive ROA of 10.58%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: AppLovin's debt-to-equity ratio surpasses industry norms, standing at 3.26. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

14 Analysts Assess AppLovin: What You Need To Know

Rumors

CYBN

Trading Circulation Newsletter Mention Of CYBN

In the preceding three months, 5 analysts have released ratings for Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $24.4, a high estimate of $27.00, and a low estimate of $22.00. Surpassing the previous average price target of $23.20, the current average has increased by 5.17%.
<img src="https://www.benzinga.com/files/images/story/2025/1744311652_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Hamilton Insurance Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;------------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$23.00 &#x7C; 
&#x7C;Tommy McJoynt &#x7C;Keefe, Bruyette &amp; Woods &#x7C;Raises &#x7C;Outperform &#x7C; $25.00&#x7C;$23.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $23.00&#x7C;$21.00 &#x7C; 
&#x7C;Matthew Carletti &#x7C;Citizens Capital Markets&#x7C;Raises &#x7C;Market Outperform&#x7C; $27.00&#x7C;$25.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $25.00&#x7C;$24.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Hamilton Insurance Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Hamilton Insurance Group compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Hamilton Insurance Group's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Hamilton Insurance Group's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hamilton Insurance Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Hamilton Insurance Group Better</h2>
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
<h3>Hamilton Insurance Group: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Hamilton Insurance Group displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 15.12%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Hamilton Insurance Group's net margin is impressive, surpassing industry averages. With a net margin of 5.82%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Hamilton Insurance Group's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.46%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Hamilton Insurance Group's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.43%, the company showcases efficient use of assets and strong financial health.
Debt Management: Hamilton Insurance Group's debt-to-equity ratio is below the industry average. With a ratio of 0.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Hamilton Insurance Group Through 5 Analysts

13 analysts have expressed a variety of opinions on Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $194.0, along with a high estimate of $230.00 and a low estimate of $150.00. Observing a 6.55% increase, the current average has risen from the previous average price target of $182.08. 
<img src="https://www.benzinga.com/files/images/story/2025/1744311642_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Jazz Pharmaceuticals by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ami Fadia &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $210.00&#x7C;$210.00 &#x7C; 
&#x7C;Oren Livnat &#x7C;HC Wainwright &amp; Co. &#x7C;Raises &#x7C;Buy &#x7C; $217.00&#x7C;$200.00 &#x7C; 
&#x7C;Jeffrey Hung &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $183.00&#x7C;$175.00 &#x7C; 
&#x7C;Ashwani Verma &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $179.00&#x7C;$145.00 &#x7C; 
&#x7C;Gregory Fraser &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $230.00&#x7C;$220.00 &#x7C; 
&#x7C;Ami Fadia &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $210.00&#x7C;$210.00 &#x7C; 
&#x7C;Balaji Prasad &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $200.00&#x7C;$190.00 &#x7C; 
&#x7C;Charles Duncan &#x7C;Cantor Fitzgerald &#x7C;Raises &#x7C;Neutral &#x7C; $150.00&#x7C;$140.00 &#x7C; 
&#x7C;David Amsellem &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $176.00&#x7C;$163.00 &#x7C; 
&#x7C;Gregory Renza &#x7C;RBC Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $178.00&#x7C;$179.00 &#x7C; 
&#x7C;Jessica Fye &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $209.00&#x7C;$200.00 &#x7C; 
&#x7C;Ami Fadia &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $210.00&#x7C;$205.00 &#x7C; 
&#x7C;Mohit Bansal &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $170.00&#x7C;$130.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Jazz Pharmaceuticals. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Jazz Pharmaceuticals compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Jazz Pharmaceuticals's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Jazz Pharmaceuticals's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/JAZZ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Jazz Pharmaceuticals analyst ratings.</a>
<h2>About Jazz Pharmaceuticals</h2>
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
<h3>Unraveling the Financial Story of Jazz Pharmaceuticals</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Jazz Pharmaceuticals showcased positive performance, achieving a revenue growth rate of 7.53% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Jazz Pharmaceuticals's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 17.56% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Jazz Pharmaceuticals's ROE excels beyond industry benchmarks, reaching 4.62%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Jazz Pharmaceuticals's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.57% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.51.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JAZZ

Where Jazz Pharmaceuticals Stands With Analysts

Wells Fargo analyst Elyse Greenspan maintains Voya Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) with a Equal-Weight and lowers the price target from $79 to $69.

VOYA

Wells Fargo Maintains Equal-Weight on Voya Financial, Lowers Price Target to $69

Financial giants have made a conspicuous bearish move on Cadence Design Systems. Our analysis of options history for Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) revealed 11 unusual trades.
Delving into the details, we found 36% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $151,100, and 7 were calls, valued at $746,770.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $215.0 to $310.0 for Cadence Design Systems over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cadence Design Systems's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cadence Design Systems's substantial trades, within a strike price spectrum from $215.0 to $310.0 over the preceding 30 days.
<h3>Cadence Design Systems 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744311637_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CDNS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$14.8</td>
<td>$13.8</td>
<td>$13.8</td>
<td>$260.00</td>
<td>$307.7K</td>
<td align="right">178</td>
<td align="right">226</td>
</tr>
<tr>
<td>CDNS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$17.1</td>
<td>$17.0</td>
<td>$17.0</td>
<td>$280.00</td>
<td>$125.8K</td>
<td align="right">248</td>
<td align="right">198</td>
</tr>
<tr>
<td>CDNS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$19.3</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$280.00</td>
<td>$103.2K</td>
<td align="right">248</td>
<td align="right">123</td>
</tr>
<tr>
<td>CDNS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$17.8</td>
<td>$17.1</td>
<td>$17.8</td>
<td>$280.00</td>
<td>$85.4K</td>
<td align="right">248</td>
<td align="right">63</td>
</tr>
<tr>
<td>CDNS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$10.9</td>
<td>$9.0</td>
<td>$9.3</td>
<td>$270.00</td>
<td>$70.6K</td>
<td align="right">145</td>
<td align="right">87</td>
</tr>
</tbody>
</table>

<h3>About Cadence Design Systems</h3>
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.
<h3>Present Market Standing of Cadence Design Systems</h3>
<ul>
<li>Trading volume stands at 1,462,340, with CDNS's price down by -2.94%, positioned at $256.88.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 18 days.</li>
</ul>
<h3>What The Experts Say On Cadence Design Systems</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $200.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Underperform rating on Cadence Design Systems, which currently sits at a price target of $200. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cadence Design Systems options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

CDNS

Behind the Scenes of Cadence Design Systems's Latest Options Trends

During the last three months, 16 analysts shared their evaluations of Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">15</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Prudential Financial, revealing an average target of $121.25, a high estimate of $134.00, and a low estimate of $101.00. Highlighting a 3.31% decrease, the current average has fallen from the previous average price target of $125.40. 
<img src="https://www.benzinga.com/files/images/story/2025/1744311635_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Prudential Financial. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $108.00&#x7C;$118.00 &#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $120.00&#x7C;$125.00 &#x7C; 
&#x7C;Brian Meredith &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $122.00&#x7C;$130.00 &#x7C; 
&#x7C;John Barnidge &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $122.00&#x7C;$124.00 &#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $126.00&#x7C;$128.00 &#x7C; 
&#x7C;Nigel Dally &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $128.00&#x7C;$136.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $118.00&#x7C;$113.00 &#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $125.00&#x7C;$129.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $134.00&#x7C;$128.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $128.00&#x7C;$127.00 &#x7C; 
&#x7C;Jack Matten &#x7C;BMO Capital &#x7C;Announces &#x7C;Underperform &#x7C; $101.00&#x7C;- &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $127.00&#x7C;$129.00 &#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $129.00&#x7C;$135.00 &#x7C; 
&#x7C;John Barnidge &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $124.00&#x7C;$127.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $113.00&#x7C;$115.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $115.00&#x7C;$117.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Prudential Financial. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Prudential Financial compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Prudential Financial's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Prudential Financial's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PRU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Prudential Financial analyst ratings.</a>
<h2>All You Need to Know About Prudential Financial</h2>
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset-management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 10% of its earnings and has around $1.3 trillion in assets under management. The US businesses are responsible for about 50% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
<h3>Prudential Financial's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Challenges: Prudential Financial's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -17.24%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Prudential Financial's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -0.44%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Prudential Financial's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.19%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Prudential Financial's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.01%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.77, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Prudential Financial: Insights From 16 Analyst Reviews

Press Releases

Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Presidio Property Trust Announces Update of Share Repurchase Program

Dividends

Presidio Property Trust Announces Series D Preferred Stock Cash Dividend

Presidio Property Trust Provides Update on Model Home Activity in Q4 2024

Presidio Property Trust Announces Sales of Union Town Center and Research Parkway Properties

General

Presidio Property Trust Provides Update on Real Estate Activity in January and February 2025

Earnings

Real Estate

Presidio Property Trust, Inc. Announces Earnings for the Year Ended December 31, 2024

CORRECTION – Presidio Property Trust, Inc. Announces Earnings for the Year Ended December 31, 2024

Presidio Property Trust Commences a Tender Offer to Repurchase up to 2,000,000 shares, plus all odd lots, of its Series A Common Stock

SQFT

SQFTP

SQFTW

American Assets Trust

Armada Hoffler Properties, Inc. Common Stock

Armada Hoffler Properties

Alexander & Baldwin, Inc. Common Stock REIT Holding Company

Alexander & Baldwin

Broadstone Net Lease

CTO Realty Growth

Essential Properties Realty Trust, Inc. Common Stock

Essential Properties

Empire State Realty OP, L.P. Series ES Operating Partnership Units Representing Limited Partnership Interests

Empire State Realty OP

Empire State Realty Trust, Inc. Class A Common Stock

Empire State Realty Trust

Generation Income Properties Inc. - Common stock

Generation Income

Global Net Lease

Gladstone Commercial Corporation - Real Estate Investment Trust

Gladstone Commercial

Modiv Industrial, Inc. Class C Common Stock

Modiv Industrial

MacKenzie Realty Capital, Inc. - Common Stock

Mackenzie Realty Capital

NexPoint Diversified Real Estate Trust Common Stock

NexPoint Diversified Real

One Liberty Properties, Inc. Common Stock

One Liberty Properties

Alpine Income Property Trust, Inc. Common Stock

Comments

Presidio Property Trust

Intérêt court

Presidio Property Trust (NASDAQ:SQFTP) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL